$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 과민성폐렴의 진단, 임상 경과 및 치료
Diagnosis, Clinical Course and Treatment of Hypersensitivity Pneumonitis 원문보기

The Korean journal of medicine = 대한내과학회지, v.99 no.2, 2024년, pp.69 - 77  

박종선 (서울대학교 의과대학 분당서울대학교병원 호흡기내과)

Abstract ▼ AI-Helper 아이콘AI-Helper

Hypersensitivity pneumonitis (HP) is an inflammatory and fibrosing interstitial lung disease caused by inhaled antigens in susceptible individuals. Various environmental materials can serve as inciting agents of HP. Recent guidelines have defined typical radiologic and histopathologic findings of HP...

Keyword

#과민성폐렴   #간질성 폐질환   #진단   #치료  

참고문헌 (41)

  1. Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT？clinical practice guideline. Am J Respir Crit Care Med 2020;202:e36-e69. 

    상세보기

  2. Perez ERF, Travis WD, Lynch DA, et al. Diagnosis and？evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report. Chest 2021;160:e97-e156. 

  3. The Korean Academy of Tuberculosis and Respiratory？Diseases. Interstitial lung disease (ILD) clinical practice guidelines (2023 1st revised) [Internet]. Seoul (KR): The Korean？Academy of Tuberculosis and Respiratory Diseases, c2023？[cited 2024 Feb 1]. Available from: https://www.lungkorea.org/bbs/index.html?codeguide&category&gubun&page1&number13253&modeview&keyfield&key. 

  4. Girard M, Israel-Assayag E, Cormier Y. Impaired function？of regulatory T-cells in hypersensitivity pneumonitis. Eur Respir？J 2011;37:632-639. 

    상세보기

  5. Vasakova M, Selman M, Morell F, Sterclova M, MolinaMolina M, Raghu G. Hypersensitivity pneumonitis: current？concepts of pathogenesis and potential targets for treatment.？Am J Respir Crit Care Med 2019;200:301-308. 

    상세보기

  6. Camarena A, Juarez A, Mejia M, et al. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms？in pigeon breeder's disease. Am J Respir Crit Care Med？2001;163:1528-1533. 

  7. Ley B, Newton CA, Arnould I, et al. The MUC5B promoter？polymorphism and telomere length in patients with chronic？hypersensitivity pneumonitis: an observational cohort-control study. Lancet Respir Med 2017;5:639-647. 

  8. Newton CA, Batra K, Torrealba J, et al. Telomere-related？lung fibrosis is diagnostically heterogeneous but uniformly？progressive. Eur Respir J 2016;48:1710-1720. 

  9. Ley B, Torgerson DG, Oldham JM, et al. Rare protein-altering telomere-related gene variants in patients with chronic？hypersensitivity pneumonitis. Am J Respir Crit Care Med？2019;200:1154-1163. 

  10. Leone PM, Richeldi L. Current diagnosis and management？of hypersensitivity pneumonitis. Tuberc Respir Dis (Seoul) 2020;83:122-131. 

  11. Hamblin M, Prosch H, Vasakova M. Diagnosis, course and？management of hypersensitivity pneumonitis. Eur Respir Rev？2022;31:210169. 

  12. Park MS. Diagnosis and treatment of hypersensitivity pneumonitis. J Korean Med Assoc 2009;52:49-58. 

  13. Kang J, Kim YJ, Choe J, Chae EJ, Song JW. Acute exacerbation？of fibrotic hypersensitivity pneumonitis: incidence and outcomes. Respir Res 2021;22:152. 

    상세보기

  14. Johannson KA, Barnes H, Bellanger AP, et al. Exposure assessment tools for hypersensitivity pneumonitis. An official？American Thoracic Society workshop report. Ann Am Thorac？Soc 2020;17:1501-1509. 

    상세보기

  15. Meyer KC, Raghu G, Baughman RP, et al. An official American？Thoracic Society clinical practice guideline: the clinical utility？of bronchoalveolar lavage cellular analysis in interstitial lung？disease. Am J Respir Crit Care Med 2012;185:1004-1014. 

  16. Soumagne T, Dalphin JC. Current and emerging techniques？for the diagnosis of hypersensitivity pneumonitis. Expert？Rev Respir Med 2018;12:493-507. 

  17. Iftikhar IH, Alghothani L, Sardi A, Berkowitz D, Musani AI.？Transbronchial lung cryobiopsy and video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse parenchymal？lung disease. A meta-analysis of diagnostic test accuracy. Ann？Am Thorac Soc 2017;14:1197-1211. 

  18. Lynch DA. CT phenotypes in hypersensitivity pneumonitis.？Chest 2019;155:655-656. 

    상세보기

  19. Barnett J, Molyneaux PL, Rawal B, et al. Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Eur Respir J？2019;54:1900531. 

  20. Chami HA, Diaz-Mendoza J, Chua A, et al. Transbronchial？biopsy and cryobiopsy in the diagnosis of hypersensitivity？pneumonitis among patients with interstitial lung disease.？Ann Am Thorac Soc 2021;18:148-161. 

    상세보기

  21. Alberti ML, Ruiz JMM, Fernandez ME, et al. Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. Pulmonology 2020;26:3-9. 

    상세보기

  22. Choe J, Chae EJ, Kim YJ, Do KH, Song JS, Song JW. Serial？changes of CT findings in patients with chronic hypersensitivity？pneumonitis: imaging trajectories and predictors of fibrotic？progression and acute exacerbation. Eur Radiol 2021;31:3993-4003. 

    상세보기

  23. Salisbury ML, Gu T, Murray S, et al. Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct？survival time and pulmonary function trajectory. Chest 2019;155:699-711. 

  24. Lima MS, Coletta EN, Ferreira RG, et al. Subacute and？chronic hypersensitivity pneumonitis: histopathological patterns and survival. Respir Med 2009;103:508-515. 

    상세보기

  25. De Sadeleer LJ, Hermans F, De Dycker E, et al. Impact of？BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study. Eur Respir J 2020;55:1901983. 

    상세보기

  26. Jacob J, Bartholmai BJ, Rajagopalan S, et al. Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis. Eur Radiol 2017;27:3635-3646. 

    상세보기

  27. Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG,？Pereira CAC. Change in FVC and survival in chronic fibrotic？hypersensitivity pneumonitis. Thorax 2018;73:391-392. 

    상세보기

  28. Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez？FJ, Flaherty KR. Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to？go. Am J Respir Crit Care Med 2017;196:690-699. 

    상세보기

  29. Adegunsoye A, Oldham JM, Perez ERF, et al. Outcomes of？immunosuppressive therapy in chronic hypersensitivity？pneumonitis. ERJ Open Res 2017;3:00016-2017. 

  30. Morisset J, Johannson KA, Vittinghoff E, et al. Use of mycophenolate mofetil or azathioprine for the management of？chronic hypersensitivity pneumonitis. Chest 2017;151:619-625. 

    상세보기

  31. Ferreira M, Borie R, Crestani B, et al. Efficacy and safety of？rituximab in patients with chronic hypersensitivity pneumonitis (cHP): a retrospective, multicentric, observational study.？Respir Med 2020;172:106146. 

    상세보기

  32. Flaherty KR, Wells AU, Cottin V, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med？2019;381:1718-1727. 

  33. Wells AU, Flaherty KR, Brown KK, et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the？INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med 2020;8:453-460. 

  34. Behr J, Prasse A, Kreuter M, et al. Pirfenidone in patients with？progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med？2021;9:476-486. 

  35. Perez ERF, Crooks JL, Lynch DA, et al. Pirfenidone in fibrotic？hypersensitivity pneumonitis: a double-blind, randomised？clinical trial of efficacy and safety. Thorax 2023;78:1097-1104. 

    상세보기

  36. ClinicalTrials.gov. Fibrosing ILD [Internet]. Bethesda (MD):？ClinicalTrials.gov, c2024 [cited 2024 Mar 20]. Available from:？https://clinicaltrials.gov/search?condfibrosing%20ILD&page3. 

  37. Jacobs SS, Krishnan JA, Lederer DJ, et al. Home oxygen therapy for adults with chronic lung disease. An official American？Thoracic Society clinical practice guideline. Am J Respir Crit？Care Med 2020;202:e121-e141. 

    상세보기

  38. Holland AE, Dowman LM, Hill CJ. Principles of rehabilitation？and reactivation: interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement. Respiration？2015;89:89-99. 

    상세보기

  39. Wijsenbeek MS, Holland AE, Swigris JJ, Renzoni EA.？Comprehensive supportive care for patients with fibrosing interstitial lung disease. Am J Respir Crit Care Med 2019;200:152-159. 

    상세보기

  40. Kern RM, Singer JP, Koth L, et al. Lung transplantation for？hypersensitivity pneumonitis. Chest 2015;147:1558-1565. 

    상세보기

  41. Tomioka H, Miyazaki Y, Inoue Y, et al. Japanese clinical practice guide 2022 for hypersensitivity pneumonitis. Respir？Investig 2024;62:16-43. 

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로